Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of plasma exchange with human albumin 5% in mild-to-moderate Alzheimer's disease
2005-001616-45Phase 4Completed
- Sponsor
- Instituto Grifols
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of albumin (human) in Alzheimer's disease (AD), sponsored by Instituto Grifols. Primary endpoints: Plasma beta-amyloid change per exchange and Longitudinal plasma beta-amyloid change. Started May 2006; status: completed.
02
Drugs
albumin (human)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2005-001616-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001616-45.